Advertisement
Screener

Alkermes plc. (ALKS) Increase (Decrease) in Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

Alkermes plc. Increase (Decrease) in Other Operating Liabilities

Alkermes plc. (ALKS) reported Increase (Decrease) in Other Operating Liabilities of $7.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-07-28

  • Alkermes plc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $2.12M.
  • Alkermes plc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $4.89M, a 71.48% increase year-over-year.
  • Alkermes plc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $4.61M, a 49.19% increase year-over-year.
  • Alkermes plc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $638.00K, a 85.28% decline year-over-year.
  • Alkermes plc. increase (decrease) in other operating liabilities for fiscal 2025 was $5.29M, a 37.21% decline from fiscal 2024.
  • Alkermes plc. increase (decrease) in other operating liabilities for fiscal 2024 was $8.43M, a 9.69% decline from fiscal 2023.
  • Alkermes plc. increase (decrease) in other operating liabilities for fiscal 2023 was $9.33M, a 26.65% decline from fiscal 2022.
  • Alkermes plc. increase (decrease) in other operating liabilities for fiscal 2022 was $12.73M.
Period endIncrease (Decrease) in Other Operating Liabilities 3 monthIncrease (Decrease) in Other Operating Liabilities 6 monthIncrease (Decrease) in Other Operating Liabilities 9 monthIncrease (Decrease) in Other Operating Liabilities 12 month
2026-06-30$2.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28
$7.01M
10-Q · filed 2026-07-28
$11.62M
derived: sum of 3 quarters · filed 2026-07-28
$12.26M
derived: sum of 4 quarters · filed 2026-07-28
2026-03-31$4.89M
10-Q · filed 2026-05-05
$9.50M
derived: sum of 2 quarters · filed 2026-05-05
$10.13M
derived: sum of 3 quarters · filed 2026-05-05
$7.33M
derived: sum of 4 quarters · filed 2026-07-28
2025-12-31$4.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$5.25M
derived: sum of 2 quarters · filed 2026-02-25
$2.44M
derived: sum of 3 quarters · filed 2026-07-28
$5.29M
10-K · filed 2026-02-25
2025-09-30$638.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
-$2.17M
derived: sum of 2 quarters · filed 2026-07-28
$686.00K
10-Q · filed 2025-10-28
$3.77M
derived: sum of 4 quarters · filed 2026-07-28
2025-06-30-$2.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28
$48.00K
10-Q · filed 2026-07-28
$3.14M
derived: sum of 3 quarters · filed 2026-07-28
$7.47M
derived: sum of 4 quarters · filed 2026-07-28
2025-03-31$2.85M
10-Q · filed 2026-05-05
$5.94M
derived: sum of 2 quarters · filed 2026-05-05
$10.27M
derived: sum of 3 quarters · filed 2026-05-05
$11.39M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$3.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$7.42M
derived: sum of 2 quarters · filed 2026-02-25
$8.54M
derived: sum of 3 quarters · filed 2026-02-25
$8.43M
10-K · filed 2026-02-25
2024-09-30$4.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$5.45M
derived: sum of 2 quarters · filed 2025-10-28
$5.34M
10-Q · filed 2025-10-28
$1.21M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$1.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
$1.01M
10-Q · filed 2025-07-29
-$3.12M
derived: sum of 3 quarters · filed 2026-02-25
$2.99M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31-$105.00K
10-Q · filed 2025-05-01
-$4.24M
derived: sum of 2 quarters · filed 2026-02-25
$1.88M
derived: sum of 3 quarters · filed 2026-02-25
$3.46M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31-$4.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$1.98M
derived: sum of 2 quarters · filed 2026-02-25
$3.56M
derived: sum of 3 quarters · filed 2026-02-25
$9.33M
10-K · filed 2026-02-25
2023-09-30$6.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24
$7.69M
derived: sum of 2 quarters · filed 2024-10-24
$13.47M
10-Q · filed 2024-10-24
$13.77M
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30$1.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24
$7.35M
10-Q · filed 2024-07-24
$7.66M
derived: sum of 3 quarters · filed 2025-02-12
$17.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31$5.77M
10-Q · filed 2024-05-01
$6.08M
derived: sum of 2 quarters · filed 2025-02-12
$15.42M
derived: sum of 3 quarters · filed 2025-02-12
$16.68M
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31$302.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
$9.65M
derived: sum of 2 quarters · filed 2025-02-12
$10.91M
derived: sum of 3 quarters · filed 2025-02-12
$12.73M
10-K · filed 2025-02-12
2022-09-30$9.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25
$10.61M
derived: sum of 2 quarters · filed 2023-10-25
$12.42M
10-Q · filed 2023-10-25
$12.44M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30$1.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26
$3.08M
10-Q · filed 2023-07-26
$3.10M
derived: sum of 3 quarters · filed 2024-02-21
-$1.10M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31$1.82M
10-Q · filed 2023-04-26
$1.84M
derived: sum of 2 quarters · filed 2024-02-21
-$2.35M
derived: sum of 3 quarters · filed 2024-02-21
-$2.30M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
-$4.17M
derived: sum of 2 quarters · filed 2024-02-21
-$4.12M
derived: sum of 3 quarters · filed 2024-02-21
-$4.33M
10-K · filed 2024-02-21
2021-09-30-$4.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
-$4.14M
derived: sum of 2 quarters · filed 2022-11-02
-$4.35M
10-Q · filed 2022-11-02
$5.88M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$58.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27
-$159.00K
10-Q · filed 2022-07-27
$10.08M
derived: sum of 3 quarters · filed 2023-02-16
$8.86M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31-$217.00K
10-Q · filed 2022-04-27
$10.02M
derived: sum of 2 quarters · filed 2023-02-16
$8.80M
derived: sum of 3 quarters · filed 2023-02-16
$9.10M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$10.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$9.02M
derived: sum of 2 quarters · filed 2023-02-16
$9.32M
derived: sum of 3 quarters · filed 2023-02-16
$9.37M
10-K · filed 2023-02-16
2020-09-30-$1.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
-$915.00K
derived: sum of 2 quarters · filed 2021-10-27
-$867.00K
10-Q · filed 2021-10-27
-$480.00K
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30$303.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
$351.00K
10-Q · filed 2021-07-28
$738.00K
derived: sum of 3 quarters · filed 2022-02-16
-$3.17M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31$48.00K
10-Q · filed 2021-04-28
$435.00K
derived: sum of 2 quarters · filed 2022-02-16
-$3.47M
derived: sum of 3 quarters · filed 2022-02-16
-$1.70M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31$387.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
-$3.52M
derived: sum of 2 quarters · filed 2022-02-16
-$1.75M
derived: sum of 3 quarters · filed 2022-02-16
$18.00K
10-K · filed 2022-02-16
2019-09-30-$3.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
-$2.13M
derived: sum of 2 quarters · filed 2020-10-29
-$369.00K
10-Q · filed 2020-10-29
$4.31M
derived: sum of 4 quarters · filed 2021-02-11
2019-06-30$1.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
$3.54M
10-Q · filed 2020-07-29
$8.21M
derived: sum of 3 quarters · filed 2021-02-11
$8.78M
derived: sum of 4 quarters · filed 2021-02-11
2019-03-31$1.76M
10-Q · filed 2020-04-29
$6.44M
derived: sum of 2 quarters · filed 2021-02-11
$7.01M
derived: sum of 3 quarters · filed 2021-02-11
$8.09M
derived: sum of 4 quarters · filed 2021-02-11
2018-12-31$4.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11
$5.24M
derived: sum of 2 quarters · filed 2021-02-11
$6.33M
derived: sum of 3 quarters · filed 2021-02-11
$9.00M
10-K · filed 2021-02-11
2018-09-30$569.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23
$1.65M
derived: sum of 2 quarters · filed 2019-10-23
$4.32M
10-Q · filed 2019-10-23
$3.73M
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30$1.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
$3.75M
10-Q · filed 2019-07-25
$3.17M
derived: sum of 3 quarters · filed 2020-02-13
$4.81M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31$2.67M
10-Q · filed 2019-04-25
$2.08M
derived: sum of 2 quarters · filed 2020-02-13
$3.73M
derived: sum of 3 quarters · filed 2020-02-13
$6.51M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31-$586.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
$1.06M
derived: sum of 2 quarters · filed 2020-02-13
$3.85M
derived: sum of 3 quarters · filed 2020-02-13
$6.09M
10-K · filed 2020-02-13
2017-09-30$1.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23
$4.43M
derived: sum of 2 quarters · filed 2018-10-23
$6.68M
10-Q · filed 2018-10-23
$6.76M
derived: sum of 4 quarters · filed 2019-02-15
2017-06-30$2.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26
$5.03M
10-Q · filed 2018-07-26
$5.12M
derived: sum of 3 quarters · filed 2019-02-15
$6.92M
derived: sum of 4 quarters · filed 2019-02-15
2017-03-31$2.25M
10-Q · filed 2018-04-26
$2.33M
derived: sum of 2 quarters · filed 2019-02-15
$4.14M
derived: sum of 3 quarters · filed 2019-02-15
$4.95M
derived: sum of 4 quarters · filed 2019-02-15
2016-12-31$81.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15
$1.89M
derived: sum of 2 quarters · filed 2019-02-15
$2.70M
derived: sum of 3 quarters · filed 2019-02-15
$4.59M
10-K · filed 2019-02-15
2016-09-30$1.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26
$2.62M
derived: sum of 2 quarters · filed 2017-10-26
$4.51M
10-Q · filed 2017-10-26
$6.74M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30$810.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27
$2.70M
10-Q · filed 2017-07-27
$4.93M
derived: sum of 3 quarters · filed 2018-02-16
$5.40M
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31$1.89M
10-Q · filed 2017-04-27
$4.12M
derived: sum of 2 quarters · filed 2018-02-16
$4.59M
derived: sum of 3 quarters · filed 2018-02-16
$5.04M
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31$2.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$2.70M
derived: sum of 2 quarters · filed 2018-02-16
$3.15M
derived: sum of 3 quarters · filed 2018-02-16
$3.29M
10-K · filed 2018-02-16
2015-09-30$467.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$913.00K
derived: sum of 2 quarters · filed 2016-11-02
$1.06M
10-Q · filed 2016-11-02
$4.23M
derived: sum of 4 quarters · filed 2017-02-17
2015-06-30$446.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28
$592.00K
10-Q · filed 2016-07-28
$3.77M
derived: sum of 3 quarters · filed 2017-02-17
$880.00K
derived: sum of 4 quarters · filed 2017-02-17
2015-03-31$146.00K
10-Q · filed 2016-04-28
$3.32M
derived: sum of 2 quarters · filed 2017-02-17
$434.00K
derived: sum of 3 quarters · filed 2017-02-17
$3.73M
derived: sum of 4 quarters · filed 2017-02-17
2014-12-31$3.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17
$288.00K
derived: sum of 2 quarters · filed 2017-02-17
$3.58M
derived: sum of 3 quarters · filed 2017-02-17
$3.59M
10-K · filed 2017-02-17
2014-09-30-$2.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29
$407.00K
derived: sum of 2 quarters · filed 2015-10-29
$420.00K
10-Q · filed 2015-10-29
$124.00K
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$3.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$3.31M
10-Q · filed 2015-07-30
$3.01M
derived: sum of 3 quarters · filed 2016-02-25
$3.46M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$13.00K
10-Q · filed 2015-04-30
-$283.00K
derived: sum of 2 quarters · filed 2016-02-25
$170.00K
derived: sum of 3 quarters · filed 2016-02-25
-$1.37M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31-$296.00K
derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25
$157.00K
derived: sum of 2 quarters · filed 2016-02-25
-$1.38M
10-K · filed 2016-02-25
-$291.00K
derived: sum of 4 quarters · filed 2016-02-25
2013-09-30$453.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31
-$1.09M
10-Q · filed 2013-10-31
$7.00K
10-Q · filed 2014-10-29
-$136.00K
derived: sum of 4 quarters · filed 2014-04-30
2013-06-30-$1.54M
10-Q · filed 2013-07-25
-$448.00K
10-Q · filed 2014-07-31
-$589.00K
derived: sum of 3 quarters · filed 2014-04-30
$1.77M
derived: sum of 4 quarters · filed 2014-04-30
2013-03-31$1.09M
10-Q · filed 2014-04-30
$950.00K
derived: sum of 2 quarters · filed 2014-04-30
$3.31M
derived: sum of 3 quarters · filed 2014-04-30
$3.32M
10-K · filed 2015-02-24
2012-12-31-$141.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31
$2.22M
derived: sum of 2 quarters · filed 2013-10-31
$2.23M
10-Q · filed 2013-01-31
2012-09-30$2.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31
$2.37M
10-Q · filed 2013-10-31
2012-06-30$6.00K
10-Q · filed 2013-07-25
2012-03-31$508.00K
10-KT · filed 2014-02-27
2011-03-31-$13.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-23
-$13.00K
derived: sum of 2 quarters · filed 2013-05-23
-$88.00K
10-K · filed 2013-05-23
2010-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02
-$75.00K
10-Q · filed 2012-02-02
2010-09-30-$75.00K
10-Q · filed 2011-11-03
2010-03-31-$1.64M
10-K · filed 2012-05-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76